Dallas Biotech Firm Invests $225 Million to Revive Extinct Species Including the Dodo
Colossal Biosciences aims to revive the extinct dodo bird through genetic editing.
The effort to resurrect vanished species is part of the global biodiversity crisis.
The company has previously expressed its intention to recreate the Tasmanian wolf and the woolly mammoth.
The company has secured additional funding of $150 million, bringing its total funding to $225 million.
The challenge of reviving the dodo involves inserting unique genes into a living animal's embryo.
The ultimate goal is to bring the birds back to their former habitat in Mauritius.
The project has raised ethical concerns, with some questioning if it is the best use of resources.
Colossal Biosciences sees the resurrection of extinct animals as a catalyst for conservation research.
The company aims to bring attention to the extinction crisis and advance genetic rescue tools.
Lead geneticist Beth Shapiro aims to advance genetic rescue tools with a focus on birds and avian conservation.
MORE STORIES